v3.24.1.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
General and administrative $ 1,481,215 $ 1,733,321
Research and development 4,250,786 2,552,947
Total operating expenses 5,732,001 4,286,268
Loss from operations (5,732,001) (4,286,268)
Interest income 200,950 133,782
Other income, net 90,241 284,721
NET LOSS $ (5,440,810) $ (3,867,765)
Net loss per share of common shares, basic $ (0.51) $ (0.36)
Net loss per share of common shares, diluted $ (0.51) $ (0.36)
Weighted-average number of common shares outstanding, basic 10,742,797 10,857,040
Weighted-average number of common shares outstanding, diluted 10,742,797 10,857,040

Source